Soluble Suppression of Tumorigenicity 2 (sST2)
sST2 is a prognostic biomarker that measures levels of a soluble form of the ST2 protein, which is involved in inflammatory and fibrotic processes in cardiovascular diseases.
sST2 is a prognostic biomarker for cardiovascular diseases, reflecting inflammatory and fibrotic activity.
Key facts at a glance
- Units
- ng/mL
- Clinical utility
- prognostic
- Result kind
- quantitative
- FDA-cleared
- Roche Elecsys sST2, Critical Diagnostics ST2
sST2 is a soluble form of the ST2 protein, a member of the interleukin-1 receptor family, and is involved in inflammatory and fibrotic pathways associated with cardiovascular diseases.
Elevated levels of sST2 have been linked to increased risk of adverse cardiovascular events, such as heart failure and mortality, making it a valuable prognostic tool.
The reference range for sST2 is typically 0–35 ng/mL, and levels above this range may indicate a higher risk of cardiovascular complications.
Frequently asked questions
What is the clinical significance of sST2?
How is sST2 measured?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy